Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rifampicin regimen for sputum conversion in active pulmonary tuberculosis (pilot study)
TCTR20170806001Phase 3Not yet recruiting
- Sponsor
- N/A
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin in pulmonary tuberculosis (TB), sponsored by N/A. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
rifampicin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on TCTR20170806001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170806001.